Showing results (211-220 of 641) with videos related to
Sort By:
Pageof 65
Drug and Alcohol Dependence|January 2, 2021
Barriers and facilitators to PDMP IS Success in the US: A systematic reviewHeather D Martin, Shikha S Modi, Sue S FeldmanEvolution; International Journal of Organic Evolution|June 1, 2017
MORPHOLOGICAL VARIABILITY AND ASYMMETRY IN THE CHEETAH (ACINONYX JUBATUS), A GENETICALLY UNIFORM SPECIESRobert K Wayne, William S Modi, Stephen J O'BrienCytogenetics and Cell Genetics|January 1, 1995
Confirmed assignment of a novel human tyrosine kinase gene (JAK1A) to 1p32.3-->p31.3 by nonisotopic in situ hybridizationW S Modi, W L Farrar, O M HowardEuropean Heart Journal|November 1, 1993
Origin and evaluation of depressed inotropism in hypertensive cardiomyopathyJ F Viallard, S Bonoron-Adele, P Dos Santos, et al.British Journal of Pharmacology|April 1, 1996
Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumventionP Pouna, S Bonoron-Adèle, G Gouverneur, et al.European Heart Journal|February 1, 1991
A case of the Budd Chiari syndrome attributed to a deficit in protein CT Couffinhal, J Bonnet, D Benchimol, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1991
Surgery of post-infarction ventricular septal defect: risk factors for hospital death and long-term resultsC Deville, F Fontan, J M Chevalier, et al.European Journal of Clinical Investigation|February 1, 1994
Markers of platelet activation in coronary heart disease patientsA T Nurden, L Macchi, C Bihour, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|August 1, 1994
[Effects of angiotensin II on spontaneous cytosolic calcium releases in ventricular myocytes of adult normal and hypertensive rats]S Sempé, B Stuyvers, L Tariosse, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicinP Pouna, S Bonoron-Adèle, G Gouverneur, et al.Pageof 65